| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |